Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Inclusion Criteria

• •Subject has been receiving in-center hemodialysis for ≥ 3 months and are currently on a schedule of 3 times a week.
• •Subject self-categorized themselves on the Patient Assessed Disease Severity Scale during Screening
• •Subject meets standard of care hemodialysis efficiency guidelines during the three months prior to completing Screening
• •Have demonstrated pruritus intensity on the Itch NRS during screening
• •Male or female who are at least 18 years old at the time of Screening